knowledge -WSS

knowledge

author：explore 2025-09-29 02:30:26 Page View：71782

Joaquin Duato -- health policy coverage from STAT — Johnson & Johnson CEO Joaquin Duato MICHAEL BUHOLZER/AFP via Getty Images

WASHINGTON — Merck CEO Robert Davis and Johnson & Johnson CEO Joaquin Duato have agreed to voluntarily testify before the Senate health committee, avoiding a threatened subpoena, the committee announced Friday.

The decision by the executives came after a public pressure campaign by Sanders to get the two executives and Bristol Myers Squibb CEO Chris Boerner to testify about why prices for their drugs are higher in the United States than in other countries. Sanders had scheduled a vote to subpoena the Merck and Johnson & Johnson CEOs on Jan. 31, but canceled it on Friday.

“The use of a subpoena was clearly a last resort and I’m delighted that these CEOs will be coming into our committee voluntarily,” Sanders said in a written statement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Covid vaccine financial winners and losers, from Pfizer to Novavax
Next article： Supreme Court strikes down use of affirmative action

focus

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Carbon Health diabetes program, a test of data

AdobeAdiabetesdiagnosiswasnotwhatJasonhadinmindwhenhesetoutonacross-countryroadtripwithhisfamilyinth

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

Eliminate the waiting period for sterilization covered by Medicaid

AdobeIt’stimetoacknowledgewhenalawintendedtorightanegregiouswronghasbecomeharmful—andchangeit.That’s

knowledge

leisure time

focus

Eliminate the waiting period for sterilization covered by Medicaid